Different microRNA alterations contribute to diverse outcomes following EV71 and CA16 infections: Insights from high-throughput sequencing in rhesus monkey peripheral blood mononuclear cells  by Hu, Yajie et al.
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a  b  s  t  r  a  c  t
Enterovirus  71  (EV71)  and  Coxsackievirus  A16 (CA16)  are  the  predominant  pathogens  of  hand,  foot,  and
mouth  disease  (HFMD).  Although  these  viruses  exhibit  genetic  homology,  the  clinical  manifestations
caused  by the  two viruses  have  some  discrepancies.  In addition,  the  underlying  mechanisms  leading  to
these differences  remain  unclear.  microRNAs  (miRNAs)  participate  in numerous  biological  or  patholog-
ical  processes,  including  host  responses  to  viral  infections.  Here,  we  focused  on  differences  in miRNA
expression  patterns  in rhesus  monkey  peripheral  blood  mononuclear  cells  (PBMCs)  infected  with  EV71
and  CA16  at  various  time  points  using  high-throughput  sequencing.  The  results  demonstrated  that  106
known  and  13 novel  miRNAs  exhibited  signiﬁcant  differences,  and 32 key  miRNAs  among  them  for  target
prediction  presented  opposite  trends  in the  EV71-  and  CA16-infected  samples.  GO and pathway  analysis
of  the  predicted  targets  showed  enrichment  in  14 biological  processes,  10  molecular  functions,  8 cellu-
lar components  and  104  pathways.  Subsequently,  regulatory  networks  of  miRNA-transcription  factors,
miRNA-predicted  targets,  miRNA-GOs  and  miRNA-pathways  were  constructed  to  reveal  the complex
regulatory  mechanisms  of  miRNAs  during  the infection  phase.  Ultimately,  we  analysed  hierarchical  GO
categories  of  the  predicted  targets  involved  in  immune  system  processes,  which  indicated  that  the  innate
and  adaptive  immunity  following  EV71  and CA16  infections  may  be remarkably  distinct.  In  conclusion,
this  report  is  the  ﬁrst describing  miRNA  expression  proﬁles  in PBMCs  with  EV71  and  CA16  infections
using high-throughput  sequencing.  Our  ﬁndings  could  provide  a  valuable  basis  for  further  studies  on
the  regulatory  roles  of miRNAs  related  to the  different  immune  responses  caused  by  EV71  and  CA16
infections.
© 2016  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Enterovirus 71 (EV71) and Coxsackievirus A16 (CA16) both
elong to the human enterovirus A (HEV-A) species of the Picor-
aviridae family and are the predominant aetiological agents of
and, foot, and mouth disease (HFMD), which frequently occurs in
nfants and children under 5 years of age (Mao  et al., 2014; Solomon
t al., 2010). HFMD is normally asymptomatic or manifests as a clin-
cally mild and self-limited disease characterized by a brief febrile
llness; typical vesicular rashes on the palms, soles, or buttocks; and
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357-2725/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article 
/).license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
oropharyngeal ulcers (Aswathyraj et al., 2016). However, in the last
few decades, HFMD has caused several outbreaks in the Asia-Paciﬁc
region with high numbers of deaths and severe central nervous sys-
tem complications, including aseptic meningitis, cerebella ataxia,
poliomyelitis-like paralysis, acute brainstem encephalitis, and ful-
minant neurogenic pulmonary edema (Aswathyraj et al., 2016; Koh
et al., 2016; Muehlenbachs et al., 2015). Thus, HFMD has resulted
in increasing socio-economic burdens and has become a pressing
global public health problem. Although EV71 and CA16 are both
small, non-enveloped viruses containing a single-stranded RNA
genome (7.4 kb) of positive polarity, and although both viruses
share similar genetic homology, different clinical manifestations
are caused by infections with these viruses (Mao  et al., 2014;
Solomon et al., 2010). Compared to CA16, EV71 infection more
often results in neurological disease and sometimes even death,
especially among children under 5 years old (Lee et al., 2009;
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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ao  et al., 2014; McMinn, 2002). Therefore, many studies have
ocused on EV71 and the studies of CA16 were previously largely
gnored. Moreover, an inactivated EV71 vaccine developed in main-
and China has successfully completed phase III clinical trials and
ntered into the market (Li et al., 2014a,b; Liu et al., 2014a). This
accine was shown to be safe and to provide protection against
linical EV71-associated HFMD, but it does not have cross-strain
rotective activity against HFMD induced by CA16 infection (Li
t al., 2014a; Liu et al., 2014a). Nevertheless, it has recently been
eported that about half of the increasingly sporadic HFMD cases
nd outbreak events with high lethality in China have been caused
y EV71 and CA16 circulating alternatively or together (Liu et al.,
014b). Additionally, CA16 infection can also initiate severe health
ssues and even lead to death(Mao, Wang, 2014). Hence, further
nvestigations into the underlying molecular mechanisms of EV71
nd CA16 infections in the host and additional assessments of virus-
ost interactions are required to develop new and better vaccines
o enable broad and effective protection against, and potentially
radication of, HFMD.
microRNAs (miRNAs), endogenously encoded single-stranded
NAs of approximately 20–23 nucleotides in length, act as key
egulators of gene expression at the post-transcriptional level by
argeting messenger RNAs (mRNAs) for translational repression or
egradation (Ha and Kim, 2014; Winter et al., 2009). Recent studies
evealed that miRNAs have unique expression proﬁles in cells from
he innate and adaptive immune systems and play pivotal roles in
he regulation of both cell development and function (Carissimi
t al., 2009; Xiao and Rajewsky, 2009). Furthermore, aberrant
xpression of miRNAs results in dysregulated innate and adaptive
mmunity, which can cause autoimmune diseases and haematopoi-
tic malignancies (Carissimi et al., 2009; Lee et al., 2014). Therefore,
iRNAs have been widely used as diagnostic and prognostic indi-
ators of disease type and severity in recent years. Additionally, it
as become increasingly clear that host-encoded miRNAs can posi-
ively or negatively regulate virus life cycles by directly interacting
ith target sites in viral transcripts or by modulating cellular gene
xpression, which alters host physiology, including components of
he immune system (Louten et al., 2015). Moreover, accumulating
esearch has indicated that virally encoded miRNAs can regulate
iral or cellular gene expression and therefore contribute to viral
eplication and pathogenesis (Powdrill et al., 2016; Sharma and
ingh, 2016). Thus, delineating the emerging roles of cellular and
irus-encoded miRNAs in host-pathogen interactions may  lead to
he development of new antiviral therapies that work by manipu-
ating such regulatory molecules.
Numerous studies have indicated that EV71 infection can inﬂu-
nce host miRNA expression proﬁles and that changes in these
roﬁles are involved in antiviral responses and immune escape in
V71 infection (Ho et al., 2016). In addition, our previous study ver-
ﬁed that EV71 and CA16 infections trigger remarkable alterations
n the immune response, which could be the reason why diverse
linical features are caused by the individual pathogens(Song et al.,
016; Zhang et al., 2014). Hence, based on the above studies, we
ypothesized that the host miRNAs that are induced by CA16
nfection might be distinct from those that are induced by EV71
nfection. Furthermore, although EV71 and CA16 infections stim-
late many common miRNAs, some miRNAs that are induced
how opposite expression trends between infections with the two
iruses. Peripheral blood mononuclear cells (PBMCs), consisting of
ymphocytes (T cells, B cells and NK cells), monocytes and dendritic
ells, are thought to be an essential component of the immune sys-
em, and alterations in PBMC populations are most likely linked to
he clinical features that occur during the progression of viral infec-
ion (Delves et al., 2006). Therefore, we utilized high-throughput
equencing of miRNA expression proﬁles in rhesus monkey PBMCs
nfected with EV71 and CA16 to investigate why these viruses resultemistry & Cell Biology 81 (2016) 20–31 21
in diverse immune responses and clinical features. The results from
this study could provide new perspectives regarding the mecha-
nisms underlying EV71 and CA16 pathogenesis.
2. Materials and methods
2.1. Cell culture and virus infection
PBMCs were isolated from EDTA-anticoagulated whole blood
samples from healthy rhesus monkeys with no known infections
or diseases. The PBMCs were isolated by Ficoll-Hypaque gradi-
ent centrifugation according to the manufacturer’s instructions.
Then, PBMCs plated onto 6-well plates at 2 × 105 cells per well
were cultivated in RPMI 1640 medium (Gibco, USA) supplemented
with 10% foetal bovine serum (FBS, Gibco, USA) plus penicillin
and streptomycin and incubated overnight at 37 ◦C in 5% CO2 in
a humidiﬁed incubator. The EV71 virus strain (sub-genotype C4,
GenBank: EU812515.1) that originated from an epidemic in Fuyang,
China in 2008 and the CA16 virus G20 strain (sub-genotype B,
GenBank: JN590244.1), which originated from an HFMD patient
in Guangxi in 2010, were propagated in PBMCs at a multiplicity
of infection (MOI) of 1 the following day. Cells were infected in
triplicate and collected at 0, 24 and 48 h post infection (hpi). Cells
infected with EV71 and CA16 for 0 hpi were used as controls. We
deﬁned the different experimental groups as EV71–0 h, EV71–24 h,
EV71–48 h, CA16–0 h, CA16–24 h and CA16–48 h. Additionally, a
subset of the EV71–0 h and CA16–0 h groups were subjected to nor-
malization (the normalization value was  set to 1), and these two
groups were then designated Con.
2.2. miRNA extraction from PBMCs and quality control
miRNA extraction from each group of cells was performed using
standard mirVanaTM miRNA Isolation Kit (Ambion, USA) protocols.
RNA integrity was  then evaluated using RNA 6000 Nano LabChips
on an Agilent 2100 Bioanalyzer (Agilent Technologies, USA). To fur-
ther conﬁrm RNA quality, the total RNA degradation was estimated
by reviewing electropherograms and the RNA integrity number
(RIN) of each sample. Only samples with preserved 18S and 28S
peaks and RIN values greater than 7 were selected for miRNA pro-
ﬁle analysis. Qualiﬁed miRNA samples from three independent
experiments of each group were pooled respectively and used for
subsequent library construction and deep sequencing.
2.3. Small RNA (sRNA) library construction, sequencing and
analysis
High-throughput sequencing technology, as a powerful tool
for transcriptome analysis, not only detects known transcripts,
but also facilitates the discovery of novel transcripts (Malone and
Oliver, 2011). Small RNA library construction and sequencing was
carried out by the National Engineering Center for Biochip in Shang-
hai on an Illumina HiSeq 2000 system. For all samples, small
RNA libraries were constructed using a TruSeq Small RNA sam-
ple preparation kit (Illumina, USA) following the manufacturer’s
instructions and were sequenced with an Illumina Genome Ana-
lyzer II system. Adaptor sequences were ﬁrst trimmed from small
RNA reads. Then, low-quality sequences, namely, those with unde-
termined nucleotides (Ns), quality scores (Q-scores) less than 10,
and reads shorter than 18nt, were discarded from all libraries.
Clipped high-quality sequences were clustered into unique reads,
and sRNAs with a length of 18–35nt were identiﬁed. Moreover,
non-coding RNAs, including ribosomal RNA (rRNA), transfer RNA
(tRNA), and small nuclear RNA (snRNA), were eliminated based
on reference sequences from Rfam (http://rfam.janelia.org/) and
piRNA (http://pirnabank.ibab.ac.in/). Afterward, the clean reads
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ere mapped to known miRNA precursors, and the mature miR-
As were deposited in miRBase 19.0 (available online: http://
ww.mirbase.org/). Unmappable sequences were used to predict
otentially novel candidate miRNAs with the Mfold RNA folding
rediction web server (available online: http://mfold.rna.albany.
du/). The sequencing data were submitted to the Gene Expression
mnibus (GEO) database (www.ncbi.nlm.nih.gov/geo/) under the
ccession number GSE85820.
.4. Bioinformatic analysis of sequencing data
.4.1. Principal component analysis (PCA)
After data preprocessing, to explore relationships between sam-
les, PCA plots of the samples were created using the clean data
hrough a median centering of the data set.
.4.2. Differential analysis of known and novel miRNAs
The samples were normalized by calculating the tags per million
f total RNA reads (TPM) and used to compare the relative abun-
ances of speciﬁc miRNAs within each data set. miRNAs with a P
alue ≤ 0.05 (chi-squared test) and a fold change ≥2 or ≤0.5 were
onsidered signiﬁcantly different among the groups.
.4.3. Unsupervised hierarchical clustering
We ﬁrst deﬁned differentially expressed miRNAs using
og2-fold changes in the ratios of the detected signals [log2
infected/control)]. Then, unsupervised hierarchical clustering
nalyses of differentially expressed miRNAs were performed using
he R computer program. Correlation similarity matrixes and com-
lete linkage algorithms were used for the cluster analyses.
.4.4. Trend analysis
To isolate pivotal differences between the EV71- and CA16-
nfected samples, we identiﬁed a set of unique expression patterns
n accordance with different signal density changes in miRNAs
nder different situations.
.4.5. miRNA target prediction
The potential targets of the differentially expressed miRNAs
ere predicted with two miRNA target prediction algorithms: Tar-
etScan and miRDB (Lewis et al., 2003; Wong and Wang, 2015).
he parameters for TargetScan and miRDB were set as the top 200
enes and a target score ≥80, respectively.
.4.6. Gene ontology (GO) analysis and Kyoto encyclopedia of
enes and genomes (KEGG) pathway analysis
The PANTHER (Protein ANalysis THrough Evolutionary Relation-
hips) classiﬁcation system version 9.0 was used to classify genes
nd proteins to facilitate high-throughput analysis. The targets of
ifferentially expressed miRNAs were subjected to GO and KEGG
athway analysis using the PANTHER Classiﬁcation System.
.4.7. Regulatory network analysis
A single miRNA can not only provoke a chain reaction but
lso be regulated by various transcription factors (TFs). Therefore,
nalysing the correlations between TFs and miRNAs, miRNAs and
argets, miRNAs and GOs, and miRNAs and pathways might reveal
 fundamental biological function of miRNAs. The intricate reg-
latory networks identiﬁed by computational approaches could
learly delineate the roles of miRNAs. To acquire an understand-
ng of the regulatory relationships formed by miRNAs and TFs,
Fs were predicted using the Ensembl web tool, and the promoter
egion of the miRNA was deﬁned as a 2-kb region up-stream of the
ranscription start site. Meanwhile, to further reduce false positive
redictions of TFs, a relative score of ≥0.99 was regarded to indi-
ate a potential TF. Thereafter, based on interactions between keyemistry & Cell Biology 81 (2016) 20–31
differentially expressed miRNAs and their targets, target genes and
GOs, and targets and pathways, regulatory networks for miRNAs,
including a miRNA-targets network, a miRNA-GOs network and a
miRNA-pathways network, were constituted.
2.4.8. Hierarchical GO category analysis of target genes involved
in GO-biological processes of interest
We primarily focused on the immune-related GOs. GO category
trees were hierarchically constructed using the PANTHER classiﬁ-
cation system.
2.4.9. Gene co-expression network construction
The GenMANIA algorithm was  applied to construct the network
of immune-related target genes that were predominantly involved
in the above hierarchical GO categories according to the relation-
ships among the genes, proteins and compounds in the database.
2.5. Validation of miRNAs and miRNA target genes by
quantitative RT-PCR (qRT-PCR) analysis
For further validation, we randomly selected 8 differentially
expressed miRNAs for qRT-PCR analysis. miRNA expression was
tested by poly (A)-tailed qRT-PCR. For each sample, 2 g of total
RNA was  polyadenylated and reverse transcribed using poly(A)
polymerase with a Mir-X miRNA First-Strand Synthesis Kit (Clon-
tech, USA), in accordance with the manufacturer’s instructions.
Subsequently, each cDNA was ampliﬁed on a 7500 Fast Real-time
PCR system (Applied Biosystems, USA) with an mRQ  3′ primer and
miRNA-speciﬁc 5′ primers to quantify speciﬁc miRNA sequences;
the ampliﬁcations were performed using SYBR Advantage qPCR
Premix (Clontech, USA). The ampliﬁcation conditions were as fol-
lows: 95 ◦C for 10 s, 40 cycles of 95 ◦C for 10 s and 60 ◦C for 40 s,
and dissociation at 95 ◦C for 60 s, 55 ◦C for 30 s and 95 ◦C for 30 s. All
miRNA-speciﬁc 5′ primers used in the qPCR experiments are shown
in Supplementary Table S1 in the online version at DOI: 10.1016/
j.biocel.2016.10.011. Samples (n = 3) were run simultaneously for
each miRNA in triplicate, including a no-template control, and U6
snRNA was  used as an endogenous control for normalization. The
relative expression levels of each miRNA were calculated from the
equation 2−Ct.
To indirectly corroborate miRNA expression, target mRNA lev-
els were measured by qRT-PCR. Total RNA was extracted using
TRIzol Reagent (TIANGEN, China) according to the manufacturer’s
instructions. qRT-PCR was performed using a One Step SYBR®
PrimeScriptTM RT-PCR Kit (TAKARA, Japan). The ampliﬁcation
cycles consisted of 1 cycle at 42 ◦C for 5 min  and 1 cycle at 95 ◦C for
10 s, followed by a two-step procedure consisting of 5 s at 95 ◦C and
34 s at 60 ◦C for 40 cycles; the reactions were run on a 7500 Fast
Real-time PCR system (Applied Biosystems, USA). -actin served
as a housekeeping gene for quantitative analysis. The qRT-PCR
primers used for each gene in this study are listed in Supplemen-
tary Table S2 in the online version at DOI: 10.1016/j.biocel.2016.10.
011. Each sample was  tested in triplicate.
2.6. MiR-146b-5p-related immune targets and downstream gene
veriﬁcation in CD1c+ dendritic cells (DCs) infected with EV71 and
CA16
The isolation of CD1c+DCs from rhesus monkey PBMCs was per-
formed by two magnetic separation steps according to the protocol
of the CD1c (BDCA-1) Dendritic Cell Isolation Kit (non-human pri-
mate, Miltenyi Biotec, Germany). The isolated cells were collected
and cultured with RPMI 1640 medium (Gibco, USA) supplemented
with 10% FBS (Gibco, USA) plus penicillin and streptomycin at 37 ◦C
in 5% CO2 in a humidiﬁed atmosphere. The EV71 virus strain and the
CA16 virus G20 strain were propagated in CD1c + DCs at an MOI  of
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Table  1
Details of small-RNA sequencing information and subsequent data analysis. Indicated from left to right are the numbers of reads that raw sequencing data, passed quality
ﬁltering (clean reads), the numbers of reads that passed both quality ﬁltering, adapter ﬁltering and length ﬁltering (adapter-trimmed reads ≥18nt), and the number of reads
that  could be aligned to known Macaca mulatta pre-miRNA in miRBase 19 with perfect matches, respectively.
Sample Raw reads Clean reads Adapter-trimmed reads
(length > = 18nt)
Reads aligned to known
Macaca mulatta
pre-miRNA in miRBase 19
EV71-0h 21,213,090 20,429,979 18,835,060 2,216,832
EV71-24h 20,682,035 18,876,048 17,483,343 5,478,275
EV71-48h 19,375,992 17,760,607 16,179,654 4,873,847
CA16-0h 20,578,052 19,217,115 17,882,021 4,452,125
CA16-24h 22,046,933 20,844,283 19,688,732 7,533,577
CA16-48h 21,740,610 20,040,877 18,558,364 6,048,592
Table 2
Signiﬁcantly differentially expressed miRNAs during the course of EV71 and CA16 infection.
Comparison Known differentially expressed miRNAs Novel differentially expressed miRNAs
Total Up Down Total Up Down
EV71–24 h vs. EV71-0h 70 6 64 6 4 2
EV71–48 h vs. EV71-0h 53 4 49 10 6 4
CA16–24 h vs. CA16-0h 32 11 21 5 3 2
CA16–48 h vs. CA16-0h 38 10 28 4 2 2
Fig. 1. Overall distribution of miRNA expression from all groups and Known differentially expressed miRNAs. (A) Overall miRNA populations are shown as a PCA plot that
i  samp
k es sh
d
1
a
a
p
t
o
e
t
S
0
2
n
m
f
sndicates the similarity and discrimination across all samples. EV71/CA16-infected
nown  differentially expressed miRNAs during infection with EV71 and CA16. Box
uring  infection with EV71 and CA16.
 the following day. Cells were infected in triplicate and harvested
t 0, 24, 48 and 72 h post infection (hpi). Cells infected with EV71
nd CA16 for 0 hpi were used as controls.
Subsequently, the extracted miRNA and mRNA of these sam-
les were used to detect the expression levels of miR-146b-5p, its
arget genes (IRAK1 and TRAF6) and the molecules downstream
f these targets (TNF-, IL-1 and IL-6) by qRT-PCR. The related
xperimental methods are described above and the primers used
o detect the miRNA and mRNAs are given in Supplementary Table
1 and S2 in the online version at DOI: 10.1016/j.biocel.2016.10.
11, respectively.
.7. Statistical analysis
For sequencing data, raw reads obtained from each library were
ormalized to TPM. For qRT-PCR, the data are expressed as the
ean ± standard error of mean (SEM). Statistical analysis was  per-
ormed using SPSS 18.0 (IBM SPSS, USA). P < 0.05 was considered
tatistically signiﬁcant.les were distinct from the Con sample. (B) Venn diagram showing a comparison of
ow the names of differentially expressed miRNAs that were signiﬁcantly changed
3. Results
3.1. Global statistics of six sequenced small-RNA libraries
To determine miRNA expression patterns in response to EV71
and CA16 challenge in PBMCs, 6 small-RNA libraries from all
samples were constructed and subjected to high-throughput
sequencing. An overview of the miRNA-seq data processing results
for all the samples is detailed in Table 1. As illustrated in Supple-
mentary Fig. S1 in the online version at DOI: 10.1016/j.biocel.2016.
10.011, most sequences were 20–23 nucleotides in length with a
peak at 22 nucleotides, which suggested that the libraries were
highly enriched in miRNA sequences. Additionally, a bar chart was
created to summarize the different classes of sRNAs in the sam-
ples (Supplementary Fig. S2 in the online version at DOI: 10.1016/
j.biocel.2016.10.011), and the results indicated that the miRNA
expression patterns showed distinct changes at different times
during EV71 and CA16 infection. To further clarify the overall vari-
ation in the samples, miRNA sequencing data were analysed by
PCA (Fig. 1A). The results revealed a clear separation between the
Con group and the infected groups, for both EV71 and CA16 infec-
24 Y. Hu et al. / The International Journal of Bioch
Fig. 2. Heat map  diagram depicting results of the hierarchical clustering of
known miRNAs and samples. The horizontal axis represents each group; the
vertical axis represents expression change (log2 ratio). The color scale shows the
relative expression levels of miRNA across all samples, with red showing expres-
sion levels above the mean and blue showing expression levels below the mean.emistry & Cell Biology 81 (2016) 20–31
tion. Moreover, the EV71–24 h and EV71–48 h groups were clearly
segregated from the CA16–24 h and CA16–48 h groups, whilst the
groups infected with the same virus for different lengths of time
were very similar to each other. These ﬁndings imply that a remark-
able difference likely exists between the EV71-infected groups and
the CA16-infected groups.
3.2. Differentially expressed miRNAs in response to EV71 or CA16
infection
Following EV71 infection, 76 differentially expressed miRNAs
(including 70 known and 6 novel miRNAs) were obtained at 24 hpi
based on a P value < 0.05 and a fold change ≥2 or ≤0.5. Of these, 64
known and 2 novel miRNAs were down-regulated, while 6 known
and 4 novel miRNAs were up-regulated. A total of 53 known and
10 novel miRNAs were differentially expressed at 48 hpi, with 49
known and 4 novel miRNAs down-regulated and 11 known and 3
novel miRNAs up-regulated. In contrast, following infection with
CA16, a relatively small number of differentially expressed miR-
NAs were identiﬁed in the samples. At 24 hpi, 21 known and 2
novel miRNAs were down-regulated, while 11 known and 3 novel
miRNAs were up-regulated. At 48 hpi, 28 known and 2 novel miR-
NAs were down-regulated, and 10 known and 2 novel miRNAs were
up-regulated (Table 2).
These above-described miRNAs were also represented using a
Venn diagram (Fig. 1B and Supplementary Fig. S3A in the online
version at DOI: 10.1016/j.biocel.2016.10.011). We  observed that
there were 106 known and 13 novel differentially expressed miR-
NAs in total across all time points during EV71 and CA16 infection.
Thereafter, these 106 known and 13 novel differentially expressed
miRNAs were subjected to unsupervised hierarchical clustering
analysis with log fold-change values to visually illustrate the
expression patterns of the miRNAs during EV71 and CA16 infection.
A positive log2 value indicates up-regulation, and a negative value
indicates down-regulation. The two heat maps that were gener-
ated exhibited marked discrepancies for the same strain at different
times as well as for different strains at the same times following
infection (Fig. 2 and Supplementary Fig. S3B in the online version
at DOI: 10.1016/j.biocel.2016.10.011). This result illustrated that
the known and novel miRNA expression patterns induced by EV71
and CA16 might be both strain- and time-speciﬁc.
To further conﬁrm our sequencing data, eight signiﬁcantly
differently expressed miRNAs, including miR-34c-5p, miR-182,
miR-582-5p, let-7i-3p, miR-150-5p, miR-147b and 2 novel miRNAs
(AATTGCAGACACTAGGACT and CGAGGGGGCGGGGCGGGGTC),
were chosen for qRT-PCR analysis. There were some differences
in the results because of the use of different technologies, but
overall we  observed a general consistency between qRT-PCR and
high-throughput sequencing results (Supplementary Fig. S4 in the
online version at DOI: 10.1016/j.biocel.2016.10.011).
3.3. Trend analysis of differentially expressed miRNAs
To investigate the primary reasons associated with the differ-
ences between EV71 and CA16 infection, trend analysis, which
explicitly took into account the temporal nature of the miRNA
expression proﬁles, was employed to identify which predominant
differentially expressed miRNAs presented an inverse expression
pattern over time following EV71 and CA16 infection. As shown in
Fig. 3, 35 differentially expressed known miRNAs were identiﬁed
The dendrograms show hierarchical clustering representing the similarities and dis-
similarities in expression proﬁles among samples and miRNAs. (For interpretation
of  the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article.)
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Table  3
Oppositely expressed miRNAs in response to EV71 and CA16 infection. Three miRNAs discarded are shown in red. FC, fold change.
miRNAs EV71–24 h (FC) CA16-24 h (FC) Ratio (EV71-24 h/CA16-24 h) EV71-48 h (FC) CA16-48 h (FC) Ratio (EV71-48 h/CA16-48 h)
miR-7194-3p 0.728386 3.073049 0.237024 0.272905 10.74647 0.025395
miR-204-5p 0.232901 6.876753 0.033868 0.109025 6.127458 0.017793
miR-183-5p 0.37592 3.210551 0.117089 0.155088 2.367415 0.065509
miR-215-5p 0.851179 1.861558 0.45724 0.423474 11.85056 0.035735
miR-147b 4.104396 6.30369 0.65111 7.082545 7.605951 0.931185
miR-34c-5p 0.228664 6.217014 0.03678 0.160278 6.918961 0.023165
miR-10b-5p 1.358487 6.752396 0.201186 0.514745 5.781785 0.089029
miR-193a-5p 0.208461 8.864564 0.023516 0.110265 3.680299 0.029961
miR-887 0.419111 1.772913 0.236397 0.129955 3.434945 0.037833
miR-144 1.362351 1.994015 0.68322 1.96256 2.68642 0.730549
miR-429-3p 0.362798 3.182151 0.11401 0.25879 2.632829 0.098293
miR-21-3p 1.097428 2.174922 0.504583 1.473674 2.525716 0.583468
miR-125b-2-3p 1.127264 3.802769 0.296432 1.397016 2.272184 0.614834
miR-193a-3p 0.473139 2.11061 0.224172 0.223922 2.103028 0.106476
miR-301b 0.321777 2.413131 0.133344 0.323322 1.840149 0.175704
miR-182 0.198514 1.670422 0.118841 0.16007 1.784112 0.08972
miR-582-3p 0.442937 2.265389 0.195524 0.473282 1.594796 0.296766
miR-146b-5p 0.730676 3.471624 0.210471 1.903475 1.557129 1.222426
miR-196b-5p 0.424724 1.105876 0.384061 0.499951 1.129597 0.442592
miR-19b 0.59551 1.032337 0.576857 0.485145 1.117267 0.434225
miR-30a-3p 0.28005 1.160452 0.241328 0.298896 0.963569 0.310197
miR-193b-3p 0.340223 0.633864 0.536744 0.263635 0.76574 0.344288
miR-582-5p 0.249021 0.768262 0.324135 0.367373 1.251302 0.293592
miR-19a-3p 0.749082 0.98331 0.761796 0.496507 1.189963 0.417246
let-7e-5p 0.475113 1.137091 0.417832 0.588858 1.107376 0.53176
miR-99b-5p 0.774337 1.414054 0.547601 0.451539 1.03465 0.436417
miR-708-5p 0.086098 0.590971 0.145688 0.125807 0.995846 0.126332
miR-376a-3p 0.189415 0.808697 0.234222 0.212905 0.69732 0.305319
miR-149-5p 0.395462 0.777593 0.508572 0.093036 0.54236 0.171539
miR-194-5p 0.43134 1.439971 0.299547 0.639778 1.793498 0.356721
miR-143-3p 0.421334 1.270905 0.331523 0.247414 1.358677 0.182099
miR-301a-3p 0.340265 1.641791 0.207252 0.456487 1.315707 0.346952
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cmiR-200a-3p 0.374684 1.128217 0.332103 
miR-96 0.448406 1.329685 0.337227 
miR-196a-5p 0.312368 1.47114 0.212331 
ccording to the above-mentioned search method. Furthermore, it
s interesting to note that these miRNAs are all separately gradu-
lly decreased and increased in EV71 and CA16 infection in the time
eries, suggesting that they may  greatly contribute to the key dis-
inctions induced by the two viruses. Meanwhile, it was discovered
hat the expression levels of the novel differentially expressed miR-
As in both EV71 and CA16 infection were either higher or lower
han the Con (Fig. S3B), which indicated that there was  no adverse
xpression tendency in the novel differentially expressed miR-
As. In total, 35 known miRNAs displayed an opposite expression
endency. To further narrow down the predominant differentially
xpressed miRNAs, we deﬁned a screening criterion as follows: if
he two ratios (EV71–24 h/CA16–24 h and EV71–48 h/CA16–48 h)
f one of the 35 known differentially expressed miRNAs fell
etween 0.5 and 2, it was eliminated (Table 3). After applying
his criterion, only 32 known differentially expressed miRNAs were
egarded as signiﬁcant.
.4. GO and pathway analysis of predicted targets of differentially
xpressed miRNAs
To elucidate the possible roles of the 32 known differentially
xpressed miRNAs in response to EV71 or CA16 infection, the
otential targets of these miRNAs were predicted with the Tar-
etScan and miRDB programs. We  found that there were 4377
enes and 2736 genes that were predicted to be potential targets
ith the TargetScan program and miRDB program, respectively.
nly the overlapping targets identiﬁed by both programs were
onsidered as predicted targets for each miRNA. Hence, a total of
205 targets were identiﬁed for GO analysis. The results exhibited
hat these genes were categorized as follows: 14 as biological pro-
ess (Fig. 4A), 10 as molecular function (Fig. 4B) and 8 as cellular0.311651 1.304833 0.238844
0.159809 1.140893 0.140074
0.235401 1.362494 0.172772
component (Fig. 4C). These results provide comprehensive infor-
mation on the functions of the miRNAs in PBMCs during EV71 and
CA16 infection. Next, pathway analysis based on the predicted tar-
gets revealed that the 32 miRNAs were involved in 104 pathways
(Fig. 5). Among these pathways, many were intimately correlated
with immune regulation (e.g., the apoptosis signalling pathway,
Toll receptor signalling, T cell activation, inﬂammation mediated
by chemokine and cytokine signalling, B cell activation, etc.) and
nervous system function (e.g., axon guidance mediated by netrin,
synaptic vesicle trafﬁcking, etc.), which suggested that alterations
in these miRNAs involved different immune responses and neuro-
logical symptoms induced by EV71 or CA16 infection.
3.5. miRNA regulatory networks of targets, GOs, pathways and
TFs
To explore the interactions between the targets, GOs, pathways
regulated by miRNAs and miRNAs mediated by TFs, we  constructed
regulatory networks among the miRNAs and targets, GOs, path-
ways, and TFs. Initially, to further narrow down the key targets,
we identiﬁed intersections of related genes in GO and pathway
analysis. In doing so, 151 targets were identiﬁed, as shown in Sup-
plementary Fig. S5 in the online version at DOI: 10.1016/j.biocel.
2016.10.011. Following this, 31 known differentially expressed
miRNAs, 13 biological processes and 100 pathways were identi-
ﬁed by reﬁning the correlations between the 151 targets and the
miRNAs, GOs, and pathways. Finally, the following 3 relationships
were identiﬁed: 1) relationships between 31 known differentially
expressed miRNAs and the 151 targets; 2) relationships between
13 GOs and the 151 targets and relationships among the 31 known
differentially expressed miRNAs and 151 targets; and 3) relation-
ships among 100 pathways and the 151 targets and relationships
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Fig. 3. Trend analysis of known differentially expressed miRNAs in response to EV71 an
opposite expression patterns during the progression of EV71 and CA16 infection are show
Table 4
Immune system processes related to miRNAs and their target genes.
miRNAs Target genes
miR-96, let-7e-5p, miR-30a-3p,
miR-582-5p, miR-204-5p, miR-19b,
miR-301b, miR-19a-3p, miR-301a-3p,
miR-182, miR-34c-5p, miR-200a-3p,
miR-183-5p, miR-194-5p,
miR-193b-3p, miR-193a-3p,
miR-196a-5p, miR-196b-5p,
miR-376a-3p, miR-146b-5p
TSPAN14, ADRA2C, STRBP, FAS,
NRCAM, DAB2, NPTX1, FHL1, CNTFR,
IGSF11, CALCR, WASL, IRF4, NUMB,
ADRB2, SERP1, STAU1, PHLDB2,
TSPAN12, ZFR, CCL18, IRAK1, IL15,
IGDCC4, ABHD14A, ABL2, FASLG,
ACER2, COLEC12, LEF1, PLAU, NOX3,
CRELD1, ABCB9, PAPPA, CX3CL1,
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cEDNRB, DCDC2, ROBO2, MAP3K13,
MAPK8, RUNX3, ABHD5, TRAF6,
IGDCC3, MAPK8IP1, GAB1, PPARG
mong the 31 known differentially expressed miRNAs and 151
argets. Using this information, we built 3 regulatory network dia-
rams, including a miRNA-gene network, a miRNA-GO network and
 miRNA-pathway network (Fig. 6A–C). Additionally, a TF-miRNA
etwork was established on the basis of the 31 known differen-
ially expressed miRNAs and their predicted TFs (Fig. 6D). Through
he 4 regulatory networks, we demonstrated that the miRNAs not
nly exert their complex functions through regulating their target
enes and the associated GOs and pathways but also are themselves
ediated by various TFs.
.6. Hierarchical GO category analysis, co-expression network
nalysis and detection of target genes involved in immune system
rocesses
Further, we speciﬁcally looked into the hierarchical GO cat-
gories of the deregulated miRNA-associated targets with the
mmune system processes derived from the above biological pro-
ess analyses. In the biological process categories produced by
he GO analysis, 20 known differentially expressed miRNAs and
8 targets were found to participate in immune system processes
Table 4). Moreover, these targets were submitted to a hierarchi-
al GO categories analysis, and the results showed that the 48d CA16 infection at different time points post infection. The miRNAs that showed
n in boxes.
targets were involved in 5 key subsets of biological processes,
including macrophage activation, antigen processing and presen-
tation, response to interferon-gamma, B cell-mediated immunity
and complement activation (Fig. 7A). Hence, we proposed that
the 20 known differentially expressed miRNAs could indirectly
mediate these biological processes and might be the crucial fac-
tors resulting in the differences between EV71 and CA16 infection.
In addition, the corresponding targets of the 20 known differ-
entially expressed miRNAs were used to build a co-expression
network (Fig. 7B), which contained cytokines (e.g., IL-15 and IL-21),
chemokines (e.g., CX3CL1 and CCL18), Toll-like receptors (e.g.,
TLR4) and NF-B signalling-related molecules (e.g., IRAK1, IRAK2,
TRAF6 and TRAF4), among others. These targets and co-expression
genes might provide new information regarding the underlying
distinct mechanisms caused by EV71 and CA16 infection.
Subsequently, we  randomly chose 16 of the 48 targets to further
measure to conﬁrm the miRNA sequencing data. In general, the
expression levels of these miRNAs and their targets presented an
inverse relationship based on the regulatory mechanisms of the
miRNAs. Except for EDNRB and ROBO2, the expression levels of
target genes were inversely correlated with the expression patterns
of the miRNAs regulating these target genes (Supplementary Fig. S6
in the online version at DOI: 10.1016/j.biocel.2016.10.011).
3.7. The regulatory role of miR-146b-5p on its targets and
downstream pro-inﬂammation cytokines in CD1c+DCs subjected
to EV71 and CA16 infection
miR-146, as an immune system regulator, inﬂuences the mam-
malian response to microbial and virus infection (Ma  et al., 2011).
As shown in Supplementary Fig. S7 in the online version at
DOI: 10.1016/j.biocel.2016.10.011, miR-146b-5p was  decreased in
CD1c+DCs with EV71 infection, its target genes (IRAK1 and TRAF6)
were up-regulated, and the corresponding downstream molecules
(TNF-, IL-1, IL-6) were activated. However, the expression lev-
els of these mRNAs and miR-146b-5p were opposite in CD1c+DCs
following CA16 infection. Therefore, this result further illustrated
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enerated from the putative targets of the 32 key differentially expressed miRNAs. 
ight  panel.
hat EV71 infection might trigger the immune response, while CA16
nfection might impede the immune response.. Discussion
HFMD, which is predominantly caused by EV71 and CA16, has
merged as a serious public health threat across the Asia-Paciﬁciched biological processes (A), molecular functions (B) and cellular components (C)
dicate the number of GOs annotated as unique GO terms and are presented in the
region (Koh et al., 2016). Although an inactivated EV71 vaccine was
found to be safe and to elicit strong protection against EV71 infec-
tion, the vaccine does not protect against CA16 infection (Liu et al.,
2014a). Therefore, further investigations into the factors that cause
different responses to EV17 and CA16 infections may  provide new
strategies for the development of more efﬁcacious vaccines to pre-
vent HFMD outbreaks. In this study, we  found that a total of 106
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EFig. 5. KEGG pathway analysis of the predicted targets of differentially ex
nown and 13 novel miRNAs signiﬁcantly changed in PBMCs fol-
owing EV71 and CA16 infection, and of these, both common and
nique miRNAs were identiﬁed. miRNAs are pivotal gene regula-
ors that act on mRNAs to cause either translation inhibition or
RNA degradation, and they participate in numerous physiolog-
cal and pathological processes (Ha and Kim, 2014; Sidhu et al.,
015). Hence, it is not surprising that abnormal miRNA expres-
ion may  result in the pathogenesis of multiple diseases. Growing
vidence has indicated that most virus infections alter the expres-
ion of cellular miRNA and that cellular miRNAs can modulate viral
athogenesis and replication by regulating the expression of viral
r host genes (Roberts et al., 2011; Sullivan and Ganem, 2005).
or instance, notable changes in cellular miRNAs expression levels
ere found in response to hepatitis C virus (HCV) infection (Li et al.,
016). Among these differentially expressed miRNAs, miR-122 was
ound to facilitate HCV replication by promoting the colony forma-
ion efﬁciency of the virus (Shan et al., 2007), whereas miR-196
ubstantially attenuated virus replication by directly targeting the
CV genome or indirectly binding to Bach1 (Hou et al., 2010). Many
tudies have also been conducted to explore the effects of miRNAs
n EV71 infection. Cui et al. revealed that host miRNA expression
atterns were altered in response to EV71 infection in Hep2 cells,
hich implied that certain miRNAs might be involved in the patho-
enesis of EV71 infection (Cui et al., 2010). Another study reported
 dramatic reduction in EV71 replication when DGCR8 (an essential
ofactor for miRNA biogenesis) was knocked down prior to EV71
nfection, which demonstrated that EV71 might utilize host miR-
As to enhance virus replication (Lui et al., 2014). Additionally, it
as reported that some miRNAs show differential expression lev-
ls following EV71 and CA16 infection and that three key miRNAs
miR-545, miR-324-3p, and miR-143) can be used to distinguish
V71 infection from CA16 infection in patients with HFMD (Cuied miRNAs. There are 104 pathways in total, as depicted in the pie chart.
et al., 2011). Together with these studies, our study demonstrated
two important points: 1) differential miRNA expression proﬁles
are produced at different time points following EV71 and CA16
infection; and 2) alterations of common and unique differentially
expressed miRNAs following EV71 and CA16 infection can be used
as diagnostic markers and may  be therapeutic targets that are
worth exploration. Therefore, in order to further determine the
key disparities between EV71 and CA16 infection, we identiﬁed 32
differentially expressed miRNAs that displayed an inverse expres-
sion trend between infections with the two  viruses. Many studies
have indicated that these 32 miRNAs function in various diseases.
For example, let-7e-5p was  shown to increase the migration and
tube formation of human endothelial progenitor cells by target-
ing Fas ligand (FASLG), resulting in deep vein thrombosis (DVT);
therefore, let-7e-5p could be a potential therapeutic target in DVT
treatment (Kong et al., 2016). miRNA-182 can exacerbate cerebral
ischaemia injury by inhibiting expression of inhibitory member of
the apoptosis-stimulating proteins of p53 family (iASPP); there-
fore, a novel miRNA-182-mediated mechanism may  provide new
therapeutic opportunities to enhance neuronal survival in cerebral
ischaemia injury (Yi et al., 2016). miRNA-301a-3p can aggravate
pancreatic ductal adenocarcinoma (PDAC) progression by sup-
pressing the target gene SMAD4 and is therefore regarded as an
independent prognostic factor for worse survival (Xia et al., 2015).
miRNA-204, which has frequently been investigated in different
types of cancers, acts as a tumour suppressor in colorectal cancer
by repressing RAB22A, a member of the RAS oncogene family (Yin
et al., 2014). However, the roles of differentially expressed miRNAs
in the pathogeneses of EV71 and CA16 infection were not known
and required further investigation.
To further understand the molecular pathogenesis of EV71 and
CA16, we performed GO and pathway analysis of the potential tar-
Y. Hu et al. / The International Journal of Biochemistry & Cell Biology 81 (2016) 20–31 29
Fig. 6. Predicted networks between the oppositely expressed miRNAs and their putative target genes, their putative target gene-associated GOs, their putative target gene-
associated pathways, and their putative TFs. All miRNAs are depicted as a red colored node among 4 networks. The larger the area of the nodes, the bigger the number of
connections between a miRNA and other nodes in the network. (A) Predicted network between the oppositely expressed miRNAs and their putative target genes. Putative
targets are presented yellow rounded rectangles. The width of the line represents the free energy between the miRNAs and their putative target genes. (B) Predicted network
between the oppositely expressed miRNAs and their putative target gene-associated GOs. Green rectangle nodes denote miRNAs and GOs. Edges show the inhibitory effects
of  miRNAs on GOs. (C) Predicted network between the oppositely expressed miRNAs and their putative target gene-associated pathways. Pathways are depicted as purple
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o  colour in this ﬁgure legend, the reader is referred to the web version of this artic
ets of 32 differentially expressed miRNAs. In this analysis, the
redicted functions of the targets were classiﬁed into biological
rocess, molecular function, and cellular component categories.
he observed changes in biological processes (especially related
o apoptotic processes and immune system processes) and path-
ays (especially associated with immune pathways, such as the
poptosis signalling pathway, the Toll-receptor signalling path-
ay, T cell activation, interleukin signalling, interferon-gamma
ignalling, inﬂammation mediated by chemokine and cytokine sig-
alling, the FAS signalling pathway and B cell activation) suggested
hat the regulation of these miRNAs plays important roles in mod-
lating immune responses and the viral pathogenesis of EV71
nd CA16 infection. Additionally, an increasing number of stud-
es have veriﬁed that miRNAs play a critical role in regulating
he immune response, including the differentiation, proliferation,
ell fate determination, and function of immune cells as well
s in inﬂammatory mediator release and in modulating intra-
ellular signalling pathways (Sonkoly et al., 2008; Winter, Jung,
009). Hence, the identiﬁcation of miRNAs involved in immune
esponse processes is essential for identifying miRNA regulatory
echanisms. Consequently, the current study’s establishment ofays. (D) Light blue rounded rectangles represent TFs. The grey lines between the
ss proportional to the magnitude of correlation. (For interpretation of the references
regulatory networks provides new insights into the interactions
that form between miRNAs and targets, miRNAs and GOs, miR-
NAs and signalling pathways, and miRNAs and TFs, all of which
contribute to the viral pathogenesis.
Virus-host interactions largely determine the pathological out-
come of infection (Sullivan and Ganem, 2005). The innate immune
system, as an early defence, responds immediately to the pres-
ence of pathogens and can effectively activate antiviral programs
that serve to limit virus replication. This activation also elicits
the adaptive immune response, which initiates clearance of infec-
tious organisms (Xiao and Rajewsky, 2009). Therefore, a focus was
placed on the immune system processes originating from the GO
analysis for deeper hierarchical GO category analysis in this work.
Our results demonstrated that miRNAs implicated in immune sys-
tem processes were consistently down-regulated following EV71
infection and up-regulated following CA16 infection. Moreover,
based on the theory that miRNAs are natural antisense interactors
that regulate their target genes, miRNAs can also exert a negative
regulatory effect on the corresponding GO categories of their tar-
get genes. Thus, the functions of these hierarchical GO categories,
including macrophage activation, antigen processing and presen-
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Fig. 7. Hierarchical tree graphs of GO terms and co-expression network for genes involved in immune system processes. (A) In total, 48 genes were used to generate the
GO  tree. Edges represent “parent-child” relationships of GO terms. The sizes of the pink rounded rectangles are proportional to the number of GO terms annotated to each
n  node
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ation, response to interferon-gamma, B cell-mediated immunity
nd complement activation, might be activated during EV71 infec-
ion and inhibited during CA16 infection. It was also conﬁrmed by
RT-PCR analysis that most target genes involved in immune sys-
em processes had increased expression during EV71 infection and
ecreased expression during CA16 infection. This result indirectly
uggests that there is a negative correlation between these differ-
ntially expressed miRNAs related to immune system processes
nd their target genes during EV71 and CA16 infection. To the best
f our knowledge, the above-mentioned GO terms are the central
lements of the innate immune response and adaptive immune
esponse, which are the universal mechanisms of host defence
gainst infection. As a result, the identiﬁcation of these processes by
ierarchical GO category analysis implied that remarkable differ-
nces are present in the innate and adaptive immune responses that
re induced by EV71 and CA16 infection. Additionally, the effects
f the above miRNAs (such as let-7e-5p and miRNA-146b-5p) on
mmune responses have been previously reported. Dong et al.
evealed that down-regulating the expression of let-7e-5p trig-
ered the activation of IFN- signalling in B cells, playing a role in
he pathogenesis of systemic lupus erythematosus (SLE) through
he production of pathogenic auto-antibodies (Dong et al., 2015).
n the current study, we found that let-7e-5p expression was  obvi-
usly reduced during EV71 infection and increased during CA16
nfection; therefore, we hypothesized that EV71 infection, but
ot CA16 infection, stimulates B cells to produce antibodies. An
ncreasing number of studies have veriﬁed that miRNA-146b-5p
s involved in various cancers and inﬂammatory diseases through
ts targeting of the TRAF6 and IRAK1 genes, which are the key
daptor molecules of the NF-B signalling pathway (Al-Ansari and
boussekhra, 2015; Liu et al., 2015). Much accumulated evidence
as supported that miRNAs play an important role in the reg-
lation of the NF-B signalling pathway during viral infections
Gao et al., 2014) and that the NF-B signalling pathway is crit-
cal to innate and adaptive immunity, inﬂammation, and tumour
evelopment Ma  et al., 2011). Moreover, our co-expression net-
ork result showed that some targets (TRAF6, IRAK1, MAP3K13,
APK8, etc.) and co-expression molecules (TLR4, IRAK2, TRAF4,
tc.) involved in the NF-B signalling pathway may  contribute to
he differences observed in EV71 and CA16 infection. Addition-s are target genes and blue nodes are co-expression genes. Genes with bigger size
t genes. Different color lines mean the different interactions between these genes.
to the web version of this article.)
ally, we found that miR-146b-5p was  down-regulated in CD1c+DCs
infected with EV71, resulting in a decrease of IRAK1 and TRAF6 as
well as a corresponding inhibition of downstream genes, including
TNF-, IL-1, IL-6, while the opposite expression patterns of miR-
146b-5p, IRAK1, TRAF6, TNF-, IL-1 and IL-6 were observed in
CD1c+DCs infected with CA16. Hence, the decreased expression of
miRNA-146b-5p during EV71 infection initiated the innate immune
response, whereas the increased expression of miRNA-146b-5p
during CA16 infection inhibited the innate immune response. Taken
together, these ﬁndings provide a possible explanation for the dis-
tinct clinical symptoms that result from EV71 and CA16 infection.
In conclusion, this study demonstrated for the ﬁrst time that
EV71 and CA16 infections result in speciﬁc miRNA expression pat-
terns in PBMCs. More studies are needed to dissect the relevant
roles of miRNAs in viral pathogenesis. Furthermore, we  constructed
regulatory networks of differentially expressed miRNAs screened
from trend analysis, providing a global perspective for exploring
miRNA-mediated mechanisms. Finally, our results demonstrated
that the 20 known differentially expressed miRNAs involved in
immune system processes that were identiﬁed in this study are the
key miRNAs that underlie the different immune responses induced
by EV71 and CA16 infection.
Conﬂict of interest
The authors do not have any commercial or other associations
that might pose a conﬂict of interest.
Acknowledgments
This work was  supported by National Natural Sciences Founda-
tion of China (31370192 and 81373142), Major National Science
& Technology Speciﬁc Projects (2014ZX09102042), Yunnan Major
Basic Research Program for Application (2013FA024) and Yunnan
Basic Research Program for Application (2014FB191).
 Bioch
R
A
A
C
C
C
D
D
G
H
H
H
K
K
L
L
L
L
L
L
L
L
L
of  colorectal cancer cells by downregulating RAB22A. Clin. Cancer Res. 20,
6187–6199.Y. Hu et al. / The International Journal of
eferences
l-Ansari, M.M., Aboussekhra, A., 2015. miR-146b-5p mediates p16-dependent
repression of IL-6 and suppresses paracrine procarcinogenic effects of breast
stromal ﬁbroblasts. Oncotarget 6, 30006–30016.
swathyraj, S., Arunkumar, G., Alidjinou, E.K., Hober, D., 2016. Hand, foot and
mouth disease (HFMD): emerging epidemiology and the need for a vaccine
strategy. Med. Microbiol. Immunol. (Berl) 205, 397–407.
arissimi, C., Fulci, V., Macino, G., 2009. MicroRNAs: novel regulators of immunity.
Autoimmun. Rev. 8, 520–524.
ui, L., Guo, X., Qi, Y., Qi, X., Ge, Y., Shi, Z., et al., 2010. Identiﬁcation of microRNAs
involved in the host response to enterovirus 71 infection by a deep sequencing
approach. J. Biomed. Biotechnol. 2010, 425939.
ui, L., Qi, Y., Li, H., Ge, Y., Zhao, K., Qi, X., et al., 2011. Serum microRNA expression
proﬁle distinguishes enterovirus 71 and coxsackievirus 16 infections in
patients with hand-foot-and-mouth disease. PLoS One 6, e27071.
elves, P., Martin, S., Burton, D., 2006. I.R. Roitt’s Essential Immunology. Blackwell
Science, Oxford.
ong, G., Fan, H., Yang, Y., Zhao, G., You, M.,  Wang, T., et al., 2015. 17beta-Estradiol
enhances the activation of IFN-alpha signaling in B cells by down-regulating
the expression of let-7e-5p, miR-98-5p and miR-145a-5p that target
IKKepsilon. Biochim. Biophys. Acta 1852, 1585–1598.
ao, Z., Dou, Y., Chen, Y., Zheng, Y., 2014. MicroRNA roles in the NF- kappaB
signaling pathway during viral infections. BioMed Res. Int. 2014, 436097.
a, M., Kim, V.N., 2014. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol.
15, 509–524.
o, B.C., Yang, P.C., Yu, S.L., 2016. MicroRNA and pathogenesis of enterovirus
infection. Viruses 8.
ou, W.,  Tian, Q., Zheng, J., Bonkovsky, H.L., 2010. MicroRNA-196 represses Bach1
protein and hepatitis C virus gene expression in human hepatoma cells
expressing hepatitis C viral proteins. Hepatology 51, 1494–1504.
oh, W.M.,  Bogich, T., Siegel, K., Jin, J., Chong, E.Y., Tan, C.Y., et al., 2016. The
epidemiology of hand, foot and mouth disease in asia: a systematic review and
analysis. Pediatr. Infect. Dis. J. 35, e285–300.
ong, L., Du, X., Hu, N., Li, W.,  Wang, W.,  Wei, S., et al., 2016. Downregulation of
let-7e-5p contributes to endothelial progenitor cell dysfunction in deep vein
thrombosis via targeting FASLG. Thromb. Res. 138, 30–36.
ee, T.C., Guo, H.R., Su, H.J., Yang, Y.C., Chang, H.L., Chen, K.T., 2009. Diseases caused
by  enterovirus 71 infection. Pediatr. Infect. Dis. J. 28, 904–910.
ee, H.M., Nguyen, D.T., Lu, L.F., 2014. Progress and challenge of microRNA research
in  immunity. Front. Genet. 5, 178.
ewis, B.P., Shih, I.H., Jones-Rhoades, M.W.,  Bartel, D.P., Burge, C.B., 2003.
Prediction of mammalian microRNA targets. Cell 115, 787–798.
i, J.X., Mao, Q.Y., Liang, Z.L., Ji, H., Zhu, F.C., 2014a. Development of enterovirus 71
vaccines: from the lab bench to Phase III clinical trials. Expert Rev. Vacc. 13,
609–618.
i, R., Liu, L., Mo,  Z., Wang, X., Xia, J., Liang, Z., et al., 2014b. An inactivated
enterovirus 71 vaccine in healthy children. N. Engl. J. Med. 370, 829–837.
i, H., Jiang, J.D., Peng, Z.G., 2016. MicroRNA-mediated interactions between host
and hepatitis C virus. World J. Gastroenterol. 22, 1487–1496.
iu, C.C., Chow, Y.H., Chong, P., Klein, M.,  2014a. Prospect and challenges for the
development of multivalent vaccines against hand, foot and mouth diseases.
Vaccine 32, 6177–6182.
iu, W.,  Wu,  S., Xiong, Y., Li, T., Wen, Z., Yan, M.,  et al., 2014b. Co-circulation and
genomic recombination of coxsackievirus A16 and enterovirus 71 during a
large outbreak of hand, foot, and mouth disease in Central China. PLoS One 9,
e96051.
iu, J., Xu, J., Li, H., Sun, C., Yu, L., Li, Y., et al., 2015. miR-146b-5p functions as a
tumor suppressor by targeting TRAF6 and predicts the prognosis of human
gliomas. Oncotarget 6, 29129–29142.emistry & Cell Biology 81 (2016) 20–31 31
Louten, J., Beach, M., Palermino, K., Weeks, M.,  Holenstein, G.,  2015. MicroRNAs
expressed during viral infection: biomarker potential and therapeutic
considerations. Biomark. Insights 10, 25–52.
Lui, Y.L., Tan, T.L., Woo, W.H., Timms, P., Hafner, L.M., Tan, K.H., et al., 2014.
Enterovirus71 (EV71) utilise host microRNAs to mediate host immune system
enhancing survival during infection. PLoS One 9, e102997.
Ma,  X., Becker Buscaglia, L.E., Barker, J.R., Li, Y., 2011. MicroRNAs in NF-kappaB
signaling. J. Mol. Cell Biol. 3, 159–166.
Malone, J.H., Oliver, B., 2011. Microarrays, deep sequencing and the true measure
of the transcriptome. BMC  Biol. 9, 34.
Mao, Q., Wang, Y., Yao, X., Bian, L., Wu,  X., Xu, M., et al., 2014. Coxsackievirus A16:
epidemiology, diagnosis, and vaccine. Hum. Vacc. Immunother. 10, 360–367.
McMinn, P.C., 2002. An overview of the evolution of enterovirus 71 and its clinical
and  public health signiﬁcance. FEMS Microbiol. Rev. 26, 91–107.
Muehlenbachs, A., Bhatnagar, J., Zaki, S.R., 2015. Tissue tropism, pathology and
pathogenesis of enterovirus infection. J. Pathol. 235, 217–228.
Powdrill, M.H., Desrochers, G.F., Singaravelu, R., Pezacki, J.P., 2016. The role of
microRNAs in metabolic interactions between viruses and their hosts. Curr.
Opin. Virol. 19, 71–76.
Roberts, A.P., Lewis, A.P., Jopling, C.L., 2011. The role of microRNAs in viral
infection. Prog. Mol. Biol. Transl. Sci. 102, 101–139.
Shan, Y., Zheng, J., Lambrecht, R.W., Bonkovsky, H.L., 2007. Reciprocal effects of
micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus
genes in human hepatocytes. Gastroenterology 133, 1166–1174.
Sharma, N., Singh, S.K., 2016. Implications of non-coding RNAs in viral infections.
Rev. Med. Virol. 26, 356–368.
Sidhu, K., Kapoor, N.R., Pandey, V., Kumar, V., 2015. The macro world of microRNAs
in  hepatocellular carcinoma. Front. Oncol. 5, 68.
Solomon, T., Lewthwaite, P., Perera, D., Cardosa, M.J., McMinn, P., Ooi, M.H., 2010.
Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet
Infect. Dis. 10, 778–790.
Song, J., Hu, Y., Hu, Y., Wang, J., Zhang, X., Wang, L., et al., 2016. Global gene
expression analysis of peripheral blood mononuclear cells in rhesus monkey
infants with CA16 infection-induced HFMD. Virus Res. 214, 1–10.
Sonkoly, E., Stahle, M.,  Pivarcsi, A., 2008. MicroRNAs and immunity: novel players
in  the regulation of normal immune function and inﬂammation. Semin. Cancer
Biol. 18, 131–140.
Sullivan, C.S., Ganem, D., 2005. MicroRNAs and viral infection. Mol. Cell 20, 3–7.
Winter, J., Jung, S., Keller, S., Gregory, R.I., Diederichs, S., 2009. Many roads to
maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol.
11, 228–234.
Wong, N., Wang, X., 2015. miRDB: an online resource for microRNA target
prediction and functional annotations. Nucleic Acids Res. 43, D146–52.
Xia, X., Zhang, K., Cen, G., Jiang, T., Cao, J., Huang, K., et al., 2015.
MicroRNA-301a-3p promotes pancreatic cancer progression via negative
regulation of SMAD4. Oncotarget 6, 21046–21063.
Xiao, C., Rajewsky, K., 2009. MicroRNA control in the immune system: basic
principles. Cell 136, 26–36.
Yi, H., Huang, Y., Yang, F., Liu, W.,  He, S., Hu, X., 2016. MicroRNA-182 aggravates
cerebral ischemia injury by targeting inhibitory member of the ASPP family
(iASPP). Arch. Biochem. Biophys. 9861, 30141–30142.
Yin, Y., Zhang, B., Wang, W.,  Fei, B., Quan, C., Zhang, J., et al., 2014. miR-204-5p
inhibits proliferation and invasion and enhances chemotherapeutic sensitivityZhang, Y., Yang, E., Pu, J., Liu, L., Che, Y., Wang, J., et al., 2014. The gene expression
proﬁle of peripheral blood mononuclear cells from EV71-infected rhesus
infants and the signiﬁcance in viral pathogenesis. PLoS One 9, e83766.
